期刊
DRUG METABOLISM REVIEWS
卷 43, 期 4, 页码 499-523出版社
INFORMA HEALTHCARE
DOI: 10.3109/03602532.2011.602687
关键词
drug-drug interactions; organic cations; polymorphisms; proton antiporter; SLC47A1; SLC47A2; MATE1; MATE2; genetic variants; pharmacogenetics
资金
- Federal Ministry for Education and Research (BMBF
- Berlin, Germany) [031S2061C, 0315755]
- EU [PITN-GA-2009-238132]
- IZEPHA [6-0-0]
- Wilhelm Sander-Foundation [2010.059.1]
- Munchen
- Robert Bosch Foundation (Stuttgart, Germany)
Multidrug and toxin extrusion proteins (MATEs; SLC47A) are mammalian transporters being predominately expressed in the brush-border membrane of proximal tubule epithelial cells in the kidney and the canalicular membrane of hepatocytes. Functionally, MATEs act as efflux transporters for organic compounds, thereby mediating the elimination process. Two isoforms, MATE1 and 2, have been identified, and, so far, only a limited number of substrates, including clinically used drugs such as metformin and cimetidine, are known. A knockout mouse model has been established, as well, and is a valuable tool for further systematic pharmacokinetic analyses. In this review, we summarize the progress in MATE research on structural, molecular, functional, and pathophysiological aspects. Consequences of genetic variants for pharmacokinetic alterations and drug therapy are discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据